Literature DB >> 21415837

Contribution of early glycemic status in the development of severe retinopathy of prematurity in a cohort of ELBW infants.

R Chavez-Valdez1, J McGowan, E Cannon, C U Lehmann.   

Abstract

OBJECTIVE: The objective of this study is to investigate the relationship between glycemic status and severe retinopathy of prematurity (ROP). STUDY
DESIGN: This is a retrospective cohort study of 114 infants <1000 g admitted to a level IV neonatal intensive care unit within 48 h of life. A cumulative, time-weighted glucose level (TWGL) derived from plotting glucose values over time was included in logistic regression analysis to identify predictors for severe ROP. RESULT: Infants had 26.6 ± 2 weeks gestational age and had a birth weight of 782 ± 136 g. TWGL during first 10 and 30 days of life were greater in the severe ROP group (P<0.01). Unlike single events of glucose levels ≥ 150 mg dl(-1), 10 days TWGL ≥ 100 mg dl(-1) (odds ratio (OR) 5.2, P<0.02) and 30 days TWGL ≥ 118 mg dl(-1) (OR 5.7, P<0.02) were predictors for severe ROP (univariate). Multivariate regression confirmed 30 days TWGL ≥ 118 mg dl(-1) (OR 9.4 to 10) and gram-positive sepsis (OR 4.1 to 5) as predictors for severe ROP (P<0.05).
CONCLUSION: High overall glycemic status is associated with the development of severe ROP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21415837     DOI: 10.1038/jp.2011.19

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  16 in total

1.  Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.

Authors:  Zhongjie Fu; Chatarina A Lofqvist; Zhuo Shao; Ye Sun; Jean-Sebastien Joyal; Christian G Hurst; Ricky Z Cui; Lucy P Evans; Katherine Tian; John Paul SanGiovanni; Jing Chen; David Ley; Ingrid Hansen Pupp; Ann Hellstrom; Lois E H Smith
Journal:  Am J Clin Nutr       Date:  2015-02-04       Impact factor: 7.045

2.  Call for a randomized controlled trial: early glycemic control in the development of retinopathy of prematurity.

Authors:  C U Lehmann
Journal:  J Perinatol       Date:  2014-06       Impact factor: 2.521

3.  Lutein facilitates physiological revascularization in a mouse model of retinopathy of prematurity.

Authors:  Zhongjie Fu; Steven S Meng; Samuel B Burnim; Lois Eh Smith; Amy Cy Lo
Journal:  Clin Exp Ophthalmol       Date:  2017-01-29       Impact factor: 4.207

4.  Natural Language Processing for Cohort Discovery in a Discharge Prediction Model for the Neonatal ICU.

Authors:  Michael W Temple; Christoph U Lehmann; Daniel Fabbri
Journal:  Appl Clin Inform       Date:  2016-02-24       Impact factor: 2.342

Review 5.  Review: adiponectin in retinopathy.

Authors:  Zhongjie Fu; Yan Gong; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Biochim Biophys Acta       Date:  2016-05-04

6.  A prospective study on hyperglycemia and retinopathy of prematurity.

Authors:  L Mohsen; M Abou-Alam; M El-Dib; M Labib; M Elsada; H Aly
Journal:  J Perinatol       Date:  2014-03-27       Impact factor: 2.521

Review 7.  Association between neonatal hyperglycemia and retinopathy of prematurity: a meta-analysis.

Authors:  Chunyan Lei; Jianan Duan; Ge Ge; Meixia Zhang
Journal:  Eur J Pediatr       Date:  2021-06-11       Impact factor: 3.183

Review 8.  The progress of prophylactic treatment in retinopathy of prematurity.

Authors:  Hong-Bing Zhang; Xiao-Dong Wang; Kun Xu; Xiao-Gang Li
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

9.  Hyperglycaemia as a risk factor for the development of retinopathy of prematurity: A cohort study.

Authors:  Harikrishnan Vannadil; P S Moulick; M A Khan; Sandeep Shankar; Jaya Kaushik; Alok Sati
Journal:  Med J Armed Forces India       Date:  2019-07-10

10.  Successful implementation of a perioperative glycemic control protocol in cardiac surgery: barrier analysis and intervention using lean six sigma.

Authors:  Elizabeth A Martinez; Raul Chavez-Valdez; Natalie F Holt; Kelly L Grogan; Katherine W Khalifeh; Tammy Slater; Laura E Winner; Jennifer Moyer; Christoph U Lehmann
Journal:  Anesthesiol Res Pract       Date:  2011-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.